Sort
261,768 grants matching “gene therapy”
COBRE in Human Genetics
$2,198,162Trudy F Mackay · Clemson University · P20 · FY2024 · GM
COBRE in Human Genetics
$2,198,162Trudy F Mackay · Clemson University · P20 · FY2023 · GM
COBRE in Human Genetics
$2,198,162Trudy F Mackay · Clemson University · P20 · FY2025 · GM
Office of Cancer Genomics
$2,197,998John Niederhuber · Office Of The Director, Nci · ZIA · FY2009 · CA
Using Cell Priming and Telecommunications Modeling to Enhance Gene Delivery for Stem Cell Therapies
$2,197,500Angela K Pannier · University Of Nebraska Lincoln · DP2 · FY2017 · EB
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$2,197,314Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
Diverse Roles of Reactive Oxygen Species and Inflammation in Vascular Disease
$2,197,055Kathy K Griendling · Emory University · P01 · FY2013 · HL
HIV persistence in vivo
$2,196,968Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
DNA Repair in Human Cancer-Prone Genetic Diseases
$2,196,164Kenneth H Kraemer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Elafin Therapy for Lung Diseases
$2,196,011Marlene Rabinovitch · Stanford University · P01 · FY2015 · HL
University of Washington (UW) Mendelian Genomics Data Coordinating Center
$2,195,875Susanne May · University Of Washington · U24 · FY2021 · HG
UCSF PROSTATE CANCER SPORE
$2,195,771University Of California San Francisco · P50 · FY2002 · CA
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,195,535Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Combating Subclonal Evolution of Resistant Cancer Phenotypes
$2,195,349Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2021 · CA
Functional Testing of Host Genes that control HIV Latency in Primary Immune Cells
$2,195,087Alexander Marson · University Of California, San Francisco · DP2 · FY2016 · DA
T Cell Costimulatory Pathways: Functions and Interactions
$2,194,909Arlene H Sharpe · Harvard Medical School · P01 · FY2014 · AI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$2,194,470Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,194,368Carl H. June · University Of Pennsylvania · P01 · FY2021 · CA
SPORE in Skin Cancer
$2,194,229Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA
Frontotemporal Dementias: Genotypes and Phenotypes
$2,194,207Virginia M Lee · University Of Pennsylvania · P01 · FY2020 · AG
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,194,150Jay Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Pharmacology Research Associates Training Program (PRAT)
$2,193,699Pamela Marino · National Institute Of General Medical Sciences · ZIE · FY2012 · GM
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,193,298John K Hewitt · University Of Colorado · P60 · FY2012 · DA
Gene Transfer to Progenitor and Differentiated Cells
$2,193,235Weill Medical College Of Cornell Univ · P01 · FY2003 · HL
PICS: A New Horizon for Surgical Critical Care
$2,192,917Frederick A Moore · University Of Florida · P50 · FY2016 · GM